Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.7 USD | -0.55% | +1.56% | +6.13% |
12:00pm | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Jun. 06 | Transcript : Amgen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.13% | 164B | |
+43.64% | 754B | |
+39.32% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.78% | 217B | |
-1.55% | 216B | |
+0.03% | 163B | |
+0.12% | 124B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating